Penny stocks, or equities trading at under $5 a share, are typically a no-go area for most investors. Capital-intensive commercial operations in the areas of biotechnology, healthcare, and technology can force fledgling companies to rely heavily on public offerings to get off the ground. The silver lining to this story is that the small group of companies that actually use these early public offerings to build successful businesses often yield enormous returns for shareholders.
Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO)Q2 2022 Earnings CallAug 04, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and welcome to the Bionano Genomics second quarter 2022 earnings conference call.
Now's a great time to invest in companies with the potential to grow significantly in the long term.